Tyrosine Kinase Inhibitor
Mikaila Eross, PharmD; Sarah Shockley, PharmD, BCOP; Danielle Roman, PharmD, BCOP; Sarah Miller, DO; Christie Hilton, DO
Justin Liauw, PharmD; Robert Brunault, PharmD; Matt Quesenberry, MD; Brianna Bakow, MD
Jared M. Freml, PharmD; Yuliya M. Byakina, PharmD, BCOP; Lisa A. Thompson, PharmD, BCOP;
Ekim Ekinci, PharmD, MS, BCOP; Jasen K. Knudsen, PharmD, BCPS, BCOP; Chamath R. De Silva, MD; Soames F. Boyle, MD; Thomas Delate, PhD, MS
Abstract #CR05
Abstract #CR22
Abstract #CR03
Jessica Katiaj, PharmD; Rosemary Boshar, PharmD; Maryann R. Cooper, PharmD, BCOP; Gerald Gehr, MD
Carrie L. Barnhart, PharmD, BCOP, and David F. Christianson, MD
Jessica Marini, PharmD, BCOP; Bailey Bass Hammond, PharmD; Jacob Rennebaum, PharmD;
Erin Weeda, PharmD, BCPS; Jagoda Misniakiewicz, PharmD; Amy Sion, PharmD, BCOP
Reduced Starting Dose of Tyrosine Kinase Inhibitors in Patients with Metastatic Renal-Cell Carcinoma
Tia M. Stitt, PharmD; Katherine M. Saunders, PharmD, BCOP; Brooke C. Rowling, PharmD Candidate; Jennifer L. Waller, PhD; Amber B. Clemmons, PharmD, BCOP, FHOPA
- 1
- 2
Page 1 of 2
Results 1 - 10 of 13
Results 1 - 10 of 13